| 1 |
35498738 | Dose Escalation Trial of Desulfated Heparin (ODSH) in Septic Peritonitis. | 2022 |
1 |
| 2 |
32077913 | Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation. | 2020 Apr 9 |
3 |
| 3 |
31471526 | Regulatory T Cells Control PF4/Heparin Antibody Production in Mice. | 2019 Oct 1 |
6 |
| 4 |
29914979 | Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia. | 2018 Aug 16 |
1 |
| 5 |
26467272 | Further insights into the anti-PF4/heparin IgM immune response. | 2016 Apr |
2 |
| 6 |
25595736 | Critical role of CD4 T cells in PF4/heparin antibody production in mice. | 2015 Mar 12 |
5 |
| 7 |
25960020 | Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages. | 2015 Aug |
1 |
| 8 |
24816371 | New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells. | 2014 Jul |
5 |
| 9 |
20959601 | Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. | 2011 Jan 27 |
1 |
| 10 |
20961394 | CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment. | 2011 Jan |
1 |
| 11 |
21659541 | Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease. | 2011 Aug 4 |
5 |
| 12 |
20724543 | Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia. | 2010 Dec 2 |
1 |
| 13 |
19245419 | Optimization of a murine immunization model for study of PF4/heparin antibodies. | 2009 May |
1 |
| 14 |
17848616 | Determinants of PF4/heparin immunogenicity. | 2007 Dec 15 |
6 |
| 15 |
15845897 | PF4/heparin complexes are T cell-dependent antigens. | 2005 Aug 1 |
2 |
| 16 |
14764524 | Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. | 2004 Nov 15 |
3 |
| 17 |
11830470 | Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. | 2002 Feb 15 |
3 |
| 18 |
9930558 | A mouse model for heparin-induced thrombocytopenia. | 1999 Jan |
2 |
| 19 |
9558385 | Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. | 1998 May 1 |
3 |
| 20 |
9871804 | [Chemokines and the regulation of hematopoiesis]. | 1998 |
1 |
| 21 |
8562407 | Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin. | 1996 Jan |
1 |
| 22 |
3409328 | Prevention by a platelet-derived factor (platelet factor 4) of induction of low dose tolerance to pneumococcal polysaccharides. | 1988 Sep |
1 |
| 23 |
6219115 | Cell surface heparan sulfate mediates some adhesive responses to glycosaminoglycan-binding matrices, including fibronectin. | 1983 Jan |
2 |